{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:25:07Z","timestamp":1771651507051,"version":"3.50.1"},"reference-count":131,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic with alarming morbidity and mortality. The emerging epidemiological data about COVID-19 patients suggest an association between cardiovascular diseases (CVD) and SARS-CoV-2 infection, in term of clinical features at hospital admission and prognosis for disease severity. The aim of our review is to describe the cardiological features of COVID-19 patients at admission, the acute cardiac presentation, the clinical outcome for patients with underlying CVD and the pharmacological implications for disease management.<\/jats:p>","DOI":"10.3390\/jcm9061944","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T07:14:19Z","timestamp":1592982859000},"page":"1944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["COVID-19 and Heart: From Clinical Features to Pharmacological Implications"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-0360","authenticated-orcid":false,"given":"Vincenzo","family":"Russo","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bottino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-7010","authenticated-orcid":false,"given":"Andreina","family":"Carbone","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rago","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Antonio","family":"Papa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-8449","authenticated-orcid":false,"given":"Gerardo","family":"Nigro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.11.054","article-title":"The SARS-CoV S glycoprotein: Expression and functional characterization","volume":"312","author":"Xiao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nature05475","article-title":"Essential role for collectrin in renal amino acid transport","volume":"444","author":"Danilczyk","year":"2006","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., and Zuo, W. (2020). Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv.","DOI":"10.1101\/2020.01.26.919985"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_20","first-page":"E008","article-title":"Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19","volume":"48","author":"Chen","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C.A., and Gao, Y.-D. (2020). Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy.","DOI":"10.1111\/all.14238"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","author":"Liu","year":"2020","journal-title":"Chin. Med J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_27","unstructured":"Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., and Zhou, Y. (2020). Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: A systematic review and meta-analysis. Int. J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Richardson, S., Hirsch, J.S., Narasimhan, M., Crawford, J.M., McGinn, T., Davidson, K.W., Northwell, C.-R.C., Barnaby, D.P., Becker, L.B., and Chelico, J.D. (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA.","DOI":"10.1001\/jama.2020.6775"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104965","DOI":"10.1016\/j.phrs.2020.104965","article-title":"Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study","volume":"159","author":"Russo","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: From vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2018","journal-title":"Eur. Hear. J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., and Wang, W. (2020). Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China. SSRN Electron. J.","DOI":"10.2139\/ssrn.3541136"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"HLH Across Speciality Collaboration, UK COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Di Micco, P., Russo, V., Carannante, N., Imparato, M., Rodolfi, S., Cardillo, G., and Lodigiani, C. (2020). Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051371"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lippi, G., Lavie, C.J., and Sanchis-Gomar, F. (2020). Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog. Cardiovasc. Dis.","DOI":"10.1016\/j.pcad.2020.03.001"},{"key":"ref_37","unstructured":"National Center for Gerontology, N.C.R.C.f.G.D. (2020). Cardiovascular Branch of Chinese Geriatrics Society, Imaging Group of Cardiovascular Department, Beijing Medical Association. Expert Recommendations for Clinical Management of Myocardial Injury Associated With Coronavirus Disease 2019. Chin. Circ. J."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zeng, J., Huang, J., and Pan, L. (2020). How to balance acute myocardial infarction and COVID-19: The protocols from Sichuan Provincial People\u2019s Hospital. Intensiv. Care Med., 1\u20133.","DOI":"10.1007\/s00134-020-05993-9"},{"key":"ref_39","unstructured":"(2020, March 20). Available online: https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur. Hear. J."},{"key":"ref_41","first-page":"2055116919879256","article-title":"Feline coronavirus-associated myocarditis in a domestic longhair cat","volume":"5","author":"Ernandes","year":"2019","journal-title":"J. Feline Med. Surg. Open Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","article-title":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus","volume":"36","author":"Alhogbani","year":"2016","journal-title":"Ann. Saudi Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Inciardi, R.M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., Cani, D.S., Cerini, M., Farina, D., and Gavazzi, E. (2020). Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol.","DOI":"10.1001\/jamacardio.2020.1096"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hu, H., Ma, F., Wei, X., and Fang, Y. (2020). Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur. Heart J.","DOI":"10.1093\/eurheartj\/ehaa190"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/eurheartj\/ehaa253","article-title":"Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19","volume":"41","author":"Hua","year":"2020","journal-title":"Eur. Hear. J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ruan, Q., Yang, K., Wang, W., Jiang, L., and Song, J. (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med.","DOI":"10.1007\/s00134-020-05991-x"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zeng, J.H., Liu, Y., Jing, Y., Wang, F., Wu, W.-B., Li, J.-X., Wang, L., Gao, H., Wang, Y., and Dong, C.-F. (2020). First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights. Infection, 1\u20135.","DOI":"10.20944\/preprints202003.0180.v1"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00059-020-04909-z","article-title":"SARS-CoV-2: A potential novel etiology of fulminant myocarditis","volume":"45","author":"Chen","year":"2020","journal-title":"Herz"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Deng, Y., Liu, W., Liu, K., Fang, Y.-Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., and Chen, L. (2020). Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China. Chin. Med J.","DOI":"10.1097\/CM9.0000000000000824"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Onder, G., Rezza, G., and Brusaferro, S. (2020). Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA.","DOI":"10.1001\/jama.2020.4683"},{"key":"ref_51","unstructured":"Russo, V., Rago, A., Carbone, A., Bottino, R., Ammendola, E., Della Cioppa, N., Galante, D., Golino, P., and Nigro, G. (2020). Atrial Fibrillation in COVID-19. J. Cardiovasc. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., and Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"ref_53","first-page":"E005","article-title":"Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations","volume":"48","author":"Tan","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_54","first-page":"E007","article-title":"Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics","volume":"48","author":"Zhu","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_55","first-page":"E018","article-title":"Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results","volume":"48","author":"Jiang","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_56","unstructured":"(2020, May 20). Guidelines for adult cardiac failure of Extracorporeal Life Support Organization (ELSO), E. Available online: https:\/\/www.elso.org\/Portals\/0\/IGD\/Archive\/FileManager\/e76ef78eabcusersshyerdocumentselsoguidelinesforadultcardiacfailure1.3.pdf."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zeng, J.-H., Liu, Y.-X., Yuan, J., Wang, F.-X., Wu, W.-B., Li, J.-X., Wang, L.-F., Gao, H., Wang, Y., and Dong, C.-F. (2020). First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection, 1\u20135.","DOI":"10.20944\/preprints202003.0180.v1"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Chow, J., Alhussaini, A., Calvillo-Arg\u00fcelles, O., Billia, F., and Luk, A. (2020). Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO). CJC Open.","DOI":"10.1016\/j.cjco.2020.04.003"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MAT.0000000000001180","article-title":"Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO\u2014A \u201cLiving Working Document\u201d","volume":"66","author":"Rajagopal","year":"2020","journal-title":"ASAIO J."},{"key":"ref_60","unstructured":"Prevention, C.C.f.D.C.a. (2020, February 20). Centers for Disease Control and Prevention CfDCaP. Confirmed COVID-19 Cases Globally. Available online: wwwcdcgov\/coronavirus\/COVID-19\/locations-confirmedcaseshtml#map."},{"key":"ref_61","unstructured":"Istituto Superiore di Sanit\u00e0 (ISS) (2020, March 20). Available online: https:\/\/www.epicentro.iss.it\/coronavirus\/aggiornamenti."},{"key":"ref_62","first-page":"E004","article-title":"Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV","volume":"48","author":"Peng","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013Angiotensin\u2013Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Diaz, J.H. (2020). Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J. Travel Med., 27.","DOI":"10.1093\/jtm\/taaa041"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J. Virol."},{"key":"ref_70","first-page":"E014","article-title":"Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia","volume":"43","author":"Sun","year":"2020","journal-title":"Chin. J. Tuberc. Respir. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Li, J., Wang, X., Chen, J., Zhang, H., and Deng, A. (2020). Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. JAMA Cardiol.","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in Critically Ill Patients in the Seattle Region\u2014Case Series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M.L., and Lescure, F.-X. (2020). Compassionate Use of Remdesivir for Patients with Severe Covid-19. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2007016"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_77","unstructured":"(2020, April 20). Available online: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=remdesivir&cntry=&state=&city=&dist=."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chinello, P., Petrosillo, N., Pittalis, S., Biava, G., Ippolito, G., and Nicastri, E. (2017). QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient. PLoS Neglected Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006034"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5414\/CP202388","article-title":"Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults","volume":"53","author":"Kumagai","year":"2015","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir\u2013Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1310\/hct1005-328","article-title":"Electrocardiogram Abnormalities with Atazanavir and Lopinavir\/Ritonavir","volume":"10","author":"Rathbun","year":"2009","journal-title":"HIV Clin. Trials"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.qai.0000219774.20174.64","article-title":"Lopinavir\/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers","volume":"42","author":"Yeh","year":"2006","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0091270006288733","article-title":"Time-Dependent Interaction Between Lopinavir\/Ritonavir and Fexofenadine","volume":"46","author":"Rolf","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/2042098616673990","article-title":"Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: The real-life evidence","volume":"8","author":"Russo","year":"2016","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: An old drug against today\u2019s diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.ijantimicag.2020.105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_89","unstructured":"(2020, April 20). Available online: www.chictr.org.cn."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0601856","article-title":"Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities","volume":"49","author":"Biot","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., and Song, C. (2020). In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciaa237"},{"key":"ref_93","unstructured":"(2020, March 20). Available online: http:\/\/www.simit.org\/medias\/1555-covid19-linee-guida-trattamento-01mar.pdf."},{"key":"ref_94","unstructured":"(2020, March 20). Available online: https:\/\/lci.rivm.nl\/covid-19\/bijlage\/behandeladvies."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Mehra, M.R., Desai, S.S., Ruschitzka, F., and Patel, A.N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. Lancet.","DOI":"10.1016\/S0140-6736(20)31180-6"},{"key":"ref_96","unstructured":"(2020, March 20). Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novell-coronavirus-2019-ncov\/solidarity-cli-trial-for-covid-19-treatments."},{"key":"ref_97","first-page":"185","article-title":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia","volume":"43","year":"2020","journal-title":"Chin. J. Tuberc. Respir. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08923973.2013.766801","article-title":"Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement","volume":"35","author":"Vereckei","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.ijcard.2007.04.055","article-title":"Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine","volume":"127","author":"Stas","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: An analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Hulot","year":"2007","journal-title":"Rheumatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6120.1109","article-title":"Complete heart block due to chronic chloroquine toxicity managed with permanent pacemaker","volume":"1","author":"Edwards","year":"1978","journal-title":"BMJ"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy\u2014A review of the literature","volume":"35","author":"Kandolf","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.1780340125","article-title":"Heart block in systemic lupus erythematosus complicated by Pacemaker \u201cexit block\u201d","volume":"34","author":"Olken","year":"1991","journal-title":"Arthritis Rheum."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/0961203306lu2345oa","article-title":"The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: The influence on arrhythmia, heart rate variability and repolarization parameters","volume":"15","author":"Cygankiewicz","year":"2006","journal-title":"Lupus"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry Cardiomyopathy","volume":"35","author":"Acharya","year":"2012","journal-title":"Clin. Cardiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.echo.2004.09.029","article-title":"Chloroquine-induced cardiomyopathy-echocardiographic features","volume":"18","author":"Naqvi","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.105.600627","article-title":"Contrast-Enhanced Magnetic Resonance Imaging of a Patient With Chloroquine-Induced Cardiomyopathy Confirmed by Endomyocardial Biopsy","volume":"114","author":"Reffelmann","year":"2006","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2010.03.109","article-title":"Chloroquine-Induced Transition From Dilated to Restrictive Cardiomyopathy","volume":"57","author":"Pieroni","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3899\/jrheum.110959","article-title":"Cardiomyopathy Caused by Longterm Treatment with Chloroquine: A Rare Disease, or a Rare Diagnosis?","volume":"39","author":"Stroehmann","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2012.03.112","article-title":"Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy","volume":"157","author":"Frustaci","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2013.08.1644","article-title":"The MOGE(S) Classification for a Phenotype\u2013Genotype Nomenclature of Cardiomyopathy","volume":"62","author":"Arbustini","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"L217","DOI":"10.1152\/ajplung.00311.2013","article-title":"The mercurial nature of neutrophils: Still an enigma in ARDS?","volume":"306","author":"Williams","year":"2013","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virusres.2007.02.014","article-title":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)","volume":"133","author":"Cameron","year":"2008","journal-title":"Virus Res."},{"key":"ref_115","unstructured":"(2020, March 20). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04306705."},{"key":"ref_116","unstructured":"(2020, March 20). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT0431022."},{"key":"ref_117","unstructured":"(2020, March 20). The Food and Drug administration, Available online: https:\/\/www.fda.gov\/."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): A double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","article-title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): A randomised, double-blind, controlled phase 4 trial","volume":"381","author":"Gabay","year":"2013","journal-title":"Lancet"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","article-title":"Statin drug interactions and related adverse reactions: An update","volume":"17","author":"Bellosta","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3899\/jrheum.120687","article-title":"Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure","volume":"40","author":"Genovese","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Castagn\u00e9, B., Viprey, M., Martin, J., Schott, A.-M., Cucherat, M., and Soubrier, M. (2019). Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220178"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10096-005-0004-z","article-title":"Treatment of severe acute respiratory syndrome","volume":"24","author":"Lai","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1469-0691.2004.00956.x","article-title":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients","volume":"10","author":"Soo","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s40064-015-1490-9","article-title":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: A study protocol","volume":"4","author":"Arabi","year":"2015","journal-title":"SpringerPlus"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Xia, S., Zhu, Y., Liu, M., Lan, Q., Xu, W., Wu, Y., Ying, T., Liu, S., Shi, Z., and Jiang, S. (2020). Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell. Mol. Immunol., 1\u20133.","DOI":"10.1038\/s41423-020-0374-2"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., and Hu, Y. (2020). The feasibility of convalescent plasma therapy in severe COVID-19 patients: A pilot study. medRxiv.","DOI":"10.1073\/pnas.2004168117"},{"key":"ref_130","first-page":"E001","article-title":"Interpretation of \u201cGuidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)\u201d","volume":"100","author":"Lin","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_131","unstructured":"(2020, March 15). Available online: https:\/\/clinicaltrials.gov\/ct2\/results?cond=COVID19&term=convalescent+plasma&cntry=&state=&city=&dist=."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:41:08Z","timestamp":1760175668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":131,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["jcm9061944"],"URL":"https:\/\/doi.org\/10.3390\/jcm9061944","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]}}}